# Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Sep 29, 2018

- Company: [Thermo Fisher Scientific Inc.](/companies/tmo.md) (CIK 97745)
- Form: 10-Q
- Filed: 2018-11-02
- Accepted by EDGAR: Nov 2, 2018, 11:45 ET
- Period: 2018-09-29
- Accession: 0000097745-18-000040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/97745/000009774518000040/q3201810q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/97745/000009774518000040/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-09-29.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-07-01 to 2018-09-29 | $5.92bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-01-01 to 2018-09-29 | $17.85bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months, 2018-07-01 to 2018-09-29 | $240.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2018-01-01 to 2018-09-29 | $716.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-07-01 to 2018-09-29 | $1.49bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2018-01-01 to 2018-09-29 | $4.55bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-07-01 to 2018-09-29 | $912.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-01-01 to 2018-09-29 | $2.63bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-07-01 to 2018-09-29 | $162.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2018-01-01 to 2018-09-29 | $495.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-07-01 to 2018-09-29 | $101.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-01-01 to 2018-09-29 | $210.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-07-01 to 2018-09-29 | $709.0m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months, 2018-01-01 to 2018-09-29 | $2.04bn | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2018-07-01 to 2018-09-29 | $1.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-01-01 to 2018-09-29 | $5.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-07-01 to 2018-09-29 | $1.76 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-01-01 to 2018-09-29 | $5.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-07-01 to 2018-09-29 | 406,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-01-01 to 2018-09-29 | 406,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-01-01 to 2018-09-29 | $2.74bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-01-01 to 2018-09-29 | $474.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2018-01-01 to 2018-09-29 | $198.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2018-01-01 to 2018-09-29 | $250.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-09-29 | $1.10bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-09-29 | $9.57bn | us-gaap:AssetsCurrent |
| Total assets | at 2018-09-29 | $55.08bn | us-gaap:Assets |
| Current liabilities | at 2018-09-29 | $5.20bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | at 2018-09-29 | $1.01bn | us-gaap:DebtCurrent |
| Shareholders' equity | at 2018-09-29 | $26.89bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2018-09-29 | 402,576,382 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/97745/000009774518000040/q3201810q.htm

Filed Nov 2, 2018.
Source: SEC EDGAR, the filing index for accession 0000097745-18-000040. Last ingested by Listed: Nov 14, 2026, 12:05 ET. No prices; not investment advice.
